You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR CYCLOGYL


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for CYCLOGYL

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02177539 ↗ A New More Efficient Cycloplegia Scheme Unknown status Pontificia Universidad Catolica de Chile Phase 4 2014-05-01 The purpose of this study is to determine whether tropicamide + phenylephrine cyclopentolate + applied for once waiting 30 minutes to retinoscopy (new scheme) is not inferior to apply cyclopentolate alone and wait 45 minutes to retinoscopy (traditional scheme)
NCT03949101 ↗ Atropine for Children and Adolescent Myopia Progression Study Unknown status Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Phase 4 2019-05-08 Investigators are going to conduct a randomized controlled trial that myopic children are randomly allocated into two groups: combined use of 1% atropine and 0.01% atropine (experimental group) and 0.01% atropine (control group) in order to explore a better way to control myopia progression and eliminate adverse effects at the same time, provide reliably evidence for clinical guideline of atropine use in children, and investigate the mechanism of atropine on eyes.
NCT03949101 ↗ Atropine for Children and Adolescent Myopia Progression Study Unknown status Shanghai Eye Disease Prevention and Treatment Center Phase 4 2019-05-08 Investigators are going to conduct a randomized controlled trial that myopic children are randomly allocated into two groups: combined use of 1% atropine and 0.01% atropine (experimental group) and 0.01% atropine (control group) in order to explore a better way to control myopia progression and eliminate adverse effects at the same time, provide reliably evidence for clinical guideline of atropine use in children, and investigate the mechanism of atropine on eyes.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for CYCLOGYL

Condition Name

Condition Name for CYCLOGYL
Intervention Trials
Myopia 1
Refractive Errors 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for CYCLOGYL
Intervention Trials
Myopia 1
Disease Progression 1
Refractive Errors 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for CYCLOGYL

Trials by Country

Trials by Country for CYCLOGYL
Location Trials
China 1
Chile 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for CYCLOGYL

Clinical Trial Phase

Clinical Trial Phase for CYCLOGYL
Clinical Trial Phase Trials
Phase 4 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for CYCLOGYL
Clinical Trial Phase Trials
Unknown status 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for CYCLOGYL

Sponsor Name

Sponsor Name for CYCLOGYL
Sponsor Trials
Pontificia Universidad Catolica de Chile 1
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 1
Shanghai Eye Disease Prevention and Treatment Center 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for CYCLOGYL
Sponsor Trials
Other 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.